Literature DB >> 29929399

The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.

Aki Juhani Käräjämäki1,2, Janne Hukkanen2, Olavi Ukkola2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes an enormous burden to human health and health-care systems all over the world. A great proportion of this burden results from increased risk of cardiovascular diseases. Atrial fibrillation (AF) is the most common chronic heart arrhythmia globally and it increases the risk of embolic stroke and heart failure. Recent studies have explored the association between NAFLD and AF with somewhat conflicting results. However, ultrasound-verified prospective studies concur that NAFLD is associated with the incidence of AF. According to epidemiological evidence, the greater the prevalence of NALFD in a population, the stronger the association with AF incidence and prevalence. Specifically, diabetic individuals with NAFLD are at the greatest risk of AF. Additionally, the risk of AF may concentrate most in individuals with advanced NAFLD, particularly those with liver fibrosis. The possible mechanistic factors between NAFLD and AF, particularly obesity and systemic inflammation, are diverse and form a complex interplaying network. However, further studies are needed to elucidate whether NAFLD has a causative role in the development of AF. The purpose of this article is to review and discuss the epidemiologic evidence and possible mechanistic links between these two conditions. KEY MESSAGES Although epidemiologic studies have provided conflicting results on the association of NAFLD and AF, prospective studies with ultrasound-verified NAFLD concur that NAFLD is associated with about 2-fold greater incidence of AF among general population and about 6-fold greater incidence among subjects with type 2 diabetes. The risk of AF among individuals with NAFLD is increased by other cardiovascular risk factors, especially type 2 diabetes and advanced age. The possible mechanistic links between NALFD and AF are diverse, with obesity and systemic inflammation having a significant role, but further studies are needed until NAFLD can be established as a causal factor in the incidence of AF.

Entities:  

Keywords:  Atrial fibrillation; cardiovascular diseases; non-alcoholic fatty liver disease

Mesh:

Year:  2018        PMID: 29929399     DOI: 10.1080/07853890.2018.1492147

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  5 in total

Review 1.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

2.  Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation.

Authors:  Yanan Chu; Fangcong Yu; Yakui Wu; Jinxiu Yang; Jiaran Shi; Tianxin Ye; Deheng Han; Xingxiang Wang
Journal:  BMC Med Genomics       Date:  2022-07-05       Impact factor: 3.622

3.  Inhibition of TREM-1 attenuates inflammation and lipid accumulation in diet-induced nonalcoholic fatty liver disease.

Authors:  Shenzong Rao; Jingsong Huang; Zhijun Shen; Changgang Xiang; Min Zhang; Xueliang Lu
Journal:  J Cell Biochem       Date:  2019-02-25       Impact factor: 4.429

4.  The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China.

Authors:  Fang Lei; Juan-Juan Qin; Xiaohui Song; Ye-Mao Liu; Ming-Ming Chen; Tao Sun; Xuewei Huang; Ke-Qiong Deng; Xiuran Zuo; Dongai Yao; Li-Juan Xu; Huiming Lu; Gang Wang; Feng Liu; Lidong Chen; Jie Luo; Jiahong Xia; Lin Wang; QiongYu Yang; Peng Zhang; Yan-Xiao Ji; Xiao-Jing Zhang; Zhi-Gang She; Qiang Zeng; Hongliang Li; Jingjing Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

Review 5.  Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.

Authors:  Flavio Giuseppe Biccirè; Tommaso Bucci; Danilo Menichelli; Vittoria Cammisotto; Pasquale Pignatelli; Roberto Carnevale; Daniele Pastori
Journal:  Nutrients       Date:  2022-03-16       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.